Start for free
Start for free
Accelerator Life Science Partners logo

Accelerator Life Science Partners

North America, New York, United States, New York

Description

Accelerator Life Science Partners offers a comprehensive arsenal of business, scientific, and financial resources.

Investor Profile

Accelerator Life Science Partners has made 9 investments, with 0 in the past 12 months and 56% as lead.

Stage Focus

  • Series A (67%)
  • Series B (11%)
  • Pre Seed (11%)
  • Series Unknown (11%)

Country Focus

  • United States (89%)
  • Singapore (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Medical
  • Neuroscience
  • Wellness
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accelerator Life Science Partners frequently co-invest with?

Alexandria
Alexandria
North America, California, United States, San Francisco
Co-Investments: 2
Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 3
Partnership Fund for New York City
Partnership Fund for New York City
North America, New York, United States, New York
Co-Investments: 3
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 3
180 Degree Capital
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 3
WuXi AppTec
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Empire State Development
Empire State Development
North America, New York, United States, New York
Co-Investments: 3
WF
Watson Fund
North America, Washington, United States, Seattle
Co-Investments: 4
AbbVie
AbbVie
North America, Illinois, United States, North Chicago
Co-Investments: 2
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 4

What are some of recent deals done by Accelerator Life Science Partners?

Proniras

Seattle, Washington, United States

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BFeb 1, 2024
Amount Raised: $4,650,000
Automera

Singapore, Central Region, Singapore

Automera focuses on a novel therapeutic methods to develop drugs.

BiotechnologyTherapeutics
Series ASep 27, 2023
Amount Raised: $16,000,000
KayoThera

Princeton, New Jersey, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

BiotechnologyHealth CareMedical
Series AJul 19, 2023
Amount Raised: $5,200,000
KayoThera

Princeton, New Jersey, United States

KayoThera develops therapeutics used to cure late-stage and metastatic cancers.

BiotechnologyHealth CareMedical
Series AMar 16, 2022
Amount Raised: $8,000,000
Lydian Neurosciences

Seattle, Washington, United States

Lydian Neurosciences focusses on developing small molecules for the treatment of sleep disorders.

Health CareHealth Diagnostics
Pre SeedJun 24, 2021
Magnolia NeuroSciences

New York, New York, United States

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.

BiotechnologyHealth CareNeuroscienceWellness
Series AAug 13, 2018
Amount Raised: $31,000,000
Proniras

Seattle, Washington, United States

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

BiotechnologyHealth CareLife SciencePharmaceutical
Series UnknownAug 22, 2017
Amount Raised: $4,300,000
Lodo Therapeutics

New York, New York, United States

Lodo Therapeutics is a drug discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series AJan 11, 2016
Amount Raised: $17,000,000
Petra Pharma

New York, New York, United States

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AJan 6, 2016
Amount Raised: $48,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator